First Financial Corp’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-27
Closed -$6K – 321
2022
Q1
$6K Hold
27
– – ﹤0.01% 314
2021
Q4
$6K Hold
27
– – ﹤0.01% 314
2021
Q3
$8K Hold
27
– – 0.01% 307
2021
Q2
$9K Hold
27
– – 0.01% 309
2021
Q1
$8K Hold
27
– – 0.01% 302
2020
Q4
$7K Hold
27
– – 0.01% 312
2020
Q3
$8K Hold
27
– – 0.01% 311
2020
Q2
$7K Hold
27
– – 0.01% 292
2020
Q1
$9K Sell
27
-5
-16% -$1.52K 0.01% 282
2019
Q4
$9K Sell
32
-19
-37% -$5.27K 0.01% 317
2019
Q3
$12K Buy
+51
New +$11.9K 0.01% 302

Other funds holding BIIB

First Financial Corp's BIIB Position: Q2 2022 in Review

First Financial Corp sold out of Biogen (BIIB) in Q2 2022, closing a stake of 27 shares — an estimated $6K sold.

First Financial Corp first reported a position in BIIB in Q3 2019 and held it in 11 quarters. The position peaked at $12K in Q3 2019. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • First Financial Corp reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • First Financial Corp sold 27 Biogen shares in Q2 2022, an estimated $6K.
  • First Financial Corp first reported a position in Biogen in Q3 2019 and held it in 11 quarters.
  • First Financial Corp's Biogen position peaked at $12K in Q3 2019.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on First Financial Corp's 13F filing for Q2 2022, filed 15 Jul 2022.